Dec 12,2016

MicroTech Completes B Round For Diabetes Devices; Qiming Leads

Qiming Venture Partners led a Series B funding in MicroTech Medical, a Hangzhou diabetes medical device company. The size of the funding round was not disclosed.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Feb 01,2017

Lark Health Raises $20M in Series B

Lark Health, a provider of chronic disease prevention and management programs, closed a $55 million Series C funding round as well as a $15 million venture debt credit facility. The company’s Series A funding round in 2013 raised about $11 million, and its Series B funding round raised approximately $20 million in 2017, Lark Health CEO Julia Hu said.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Apr 14,2017

Chinese CGM maker POCTech raises $14.5m in Series B

Chinese continuous glucose monitor developer Zhejiang POCTech Medical has raised $14.5 million in a Series B round of financing, according to a Deal Street Asia report.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
May 28,2019

Welkin Health Raises $17.5 Million in Series B Funding from Altos Ventures

Welkin Health, a patient relationship management software company, today announced $17.5 million in Series B funding led by Altos Ventures. Existing investors, Thrive Capital, Red Swan Ventures, and Asset Management Ventures also contributed to the round, which brings Welkin’s total funding to $30 million. Welkin closed an $8 million Series A round with Thrive Capital in 2017. Since then, the company has grown from a team of 15 to 50 and more than doubled its customer base.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Jun 05,2019

Carbon Health Secures $30 Million Series B Funding To Reimagine The Consumer Healthcare Retail Experience And Accelerate Expansion Into New Markets Nationwide

Carbon Health, the technology-enabled healthcare provider designed from the ground up to put patient-care first, announced today that it has secured $30 million in Series B funding. Brookfield Growth Partners led the round, which included new investors DCVC and founders from pioneering healthcare businesses Flatiron Health and Clover Health, as well as continued support from existing investors, Builders VC, Bullpen Capital, Javelin Venture Partners and Two Sigma Ventures. Josh Raffaelli, Managing Director at Brookfield Growth Partners, has joined Carbon Health’s Board of Directors.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Oct 06,2019

Longliv invests $5m in microbiome co DayTwo

Israeli personalized nutrition company DayTwo has expanded its $31 million Series B financing round with an additional $5 million investment from Longliv Ventures and unspecified amounts from Cathay Innovation and Samsung NEXT. Longliv Ventures managing director Dr. Dan Eldar will join the company's board.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
May 11,2020

CARBON HEALTH RAISES $28 MILLION IN SERIES B1, TRIPLES STAFF, BEGINS NATIONAL VIRTUAL CARE ROLLOUT

Carbon Health, the technology-enabled healthcare provider designed from the ground up to put patient-care first, announced today that it has tripled its headcount to combat the COVID-19 pandemic and extended its virtual care service to now serve nearly two-thirds of the U.S. population. The growth was made possible by its recent strategic round of funding of $28 million led by existing investor DCVC in an extended Series B, bringing the company’s total raised capital to $75 million.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Jul 07,2021

BeatO raises USD 5.7 million in funding led by W Health Ventures

BeatO – India's leading digital care ecosystem for chronic condition management – has raised USD 5.7 million in funding led by US-based venture capital firm, W Health Ventures. The funding also saw participation from e-pharmacy Unicorn PharmEasy (a Threpsi Solutions Pvt Ltd brand), Merisis VP and existing investors Orios VP, Leo Capital, and others. With this new funding, BeatO has raised more than USD 10 million over the last year across its Series A and Pre-series B rounds.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Nov 02,2021

Biolinq Raises $100 Million, Unveils Micro-Sensing Technology in the Skin

Biolinq Incorporated, a medical device company developing a continuous glucose sensor with a novel integrated display on its wearable device, has announced the closing of a $100 million Series B financing round led by RiverVest Venture Partners. This record private capital raise in the continuous glucose monitoring space includes participation from T&W Medical, AXA IM Alts, Global Health Investment Corporation, Ascensia Diabetes Care, Longevity Vision Fund, Falcon Edge Capital, Aphelion Capital, M Ventures, Hikma Ventures, Senvest, The Broe Group, Taisho Pharmaceutical, Cirrus Logic, EOFlow, Able Partners and the JDRF T1D Fund.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Nov 16,2022

Diabetes Care App BeatO Raises $33 Million In Series B Funding Led By Lightrock India

BeatO, on November 16, announced to have raised $33 million in a series B round of funding that was led by Lightrock India with participation from HealthQuad, Flipkart and the company’s existing investors.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Subscribe to SERIES B